IRD Insider Trading
Insider Ownership Percentage: 6.60%
Insider Buying (Last 12 Months): $323,890.00
Insider Selling (Last 12 Months): $8,600,000.00
Opus Genetics Share Price & Price History
Current Price: $4.65
Price Change: ▲ Price Increase of +0.08 (1.75%)
As of 03/5/2026 11:53 AM ET
Opus Genetics Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/29/2025 | Cam Gallagher | Director | Buy | 81,000 | $1.98 | $160,380.00 | 1,891,430 | |
| 12/29/2025 | Cam Gallagher | Director | Buy | 83,000 | $1.97 | $163,510.00 | 83,000 | |
| 12/9/2025 | Fighting Blindness Foundation | Director | Sell | 4,000,000 | $2.15 | $8,600,000.00 | 5,492,171 | |
| 12/26/2024 | George Magrath | CEO | Buy | 100,000 | $0.98 | $98,000.00 | 599,150 | |
| 11/18/2024 | George Magrath | CEO | Buy | 9,706 | $1.02 | $9,900.12 | 492,950 | |
| 11/15/2024 | George Magrath | CEO | Buy | 90,294 | $1.01 | $91,196.94 | 483,244 | |
Opus Genetics Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/23/2026 | Virtu Financial LLC | 16,810 | $34K | 0.0% | N/A | 0.024% |  |
| 2/18/2026 | XTX Topco Ltd | 23,737 | $48K | 0.0% | -54.1% | 0.034% |  |
| 2/18/2026 | Occudo Quantitative Strategies LP | 12,205 | $25K | 0.0% | N/A | 0.018% |  |
| 2/18/2026 | Opaleye Management Inc. | 1,120,000 | $2.25M | 0.3% | +1.8% | 1.624% |  |
| 2/18/2026 | Millennium Management LLC | 2,002,550 | $4.03M | 0.0% | N/A | 2.904% |  |
| 2/18/2026 | Balyasny Asset Management L.P. | 2,718,029 | $5.46M | 0.0% | N/A | 3.941% |  |
| 2/17/2026 | ADAR1 Capital Management LLC | 40,000 | $80K | 0.0% | N/A | 0.058% |  |
| 2/17/2026 | Adage Capital Partners GP L.L.C. | 1,104,996 | $2.22M | 0.0% | +15.7% | 1.602% |  |
| 2/17/2026 | Blair William & Co. IL | 27,466 | $55K | 0.0% | +12.3% | 0.040% |  |
| 2/16/2026 | OMERS ADMINISTRATION Corp | 87,900 | $0.18M | 0.0% | N/A | 0.127% |  |
| 2/13/2026 | Nantahala Capital Management LLC | 4,781,330 | $9.61M | 0.3% | +42.9% | 6.933% |  |
| 2/13/2026 | Marshall Wace LLP | 157,648 | $0.32M | 0.0% | N/A | 0.229% |  |
| 2/13/2026 | Johnson Investment Counsel Inc. | 20,000 | $40K | 0.0% | N/A | 0.029% |  |
| 2/13/2026 | Mink Brook Asset Management LLC | 1,665,631 | $3.35M | 2.1% | +34.5% | 2.415% |  |
| 2/13/2026 | State Street Corp | 173,253 | $0.35M | 0.0% | +18.8% | 0.251% |  |
| 2/13/2026 | Voss Capital LP | 441,891 | $0.89M | 0.0% | -21.4% | 0.641% |  |
| 2/13/2026 | Wells Fargo & Company MN | 241,871 | $0.49M | 0.0% | +6,290.3% | 0.351% |  |
| 2/12/2026 | Renaissance Technologies LLC | 126,309 | $0.25M | 0.0% | -27.3% | 0.183% |  |
| 2/11/2026 | Regency Capital Management Inc. DE | 46,000 | $92K | 0.0% | N/A | 0.067% |  |
| 2/9/2026 | Geode Capital Management LLC | 504,983 | $1.02M | 0.0% | +7.7% | 0.732% |  |
| 2/9/2026 | Texas Capital Bank Wealth Management Services Inc | 78,000 | $0.16M | 0.0% | N/A | 0.113% |  |
| 11/20/2025 | Voss Capital LP | 562,377 | $0.93M | 0.0% | +3.9% | 0.815% |  |
| 11/17/2025 | Mink Brook Asset Management LLC | 1,237,947 | $2.04M | 1.4% | +3.4% | 1.904% |  |
| 11/17/2025 | Citadel Advisors LLC | 113,416 | $0.19M | 0.0% | +496.9% | 0.174% |  |
| 11/14/2025 | Creative Planning | 128,366 | $0.21M | 0.0% | N/A | 0.197% |  |
| 11/14/2025 | Raymond James Financial Inc. | 22,508 | $37K | 0.0% | +95.6% | 0.035% |  |
| 11/14/2025 | Two Sigma Investments LP | 108,338 | $0.18M | 0.0% | +169.6% | 0.167% |  |
| 11/7/2025 | Vanguard Group Inc. | 1,342,025 | $2.21M | 0.0% | +35.3% | 2.240% |  |
| 8/15/2025 | Opaleye Management Inc. | 1,220,000 | $1.15M | 0.2% | +3.8% | 2.045% |  |
| 8/15/2025 | Mink Brook Asset Management LLC | 1,197,616 | $1.13M | 1.0% | +47.8% | 2.007% |  |
| 8/15/2025 | Bridgeway Capital Management LLC | 42,065 | $40K | 0.0% | -63.9% | 0.071% |  |
| 8/14/2025 | Nantahala Capital Management LLC | 3,345,923 | $3.15M | 0.1% | +6.0% | 5.608% |  |
| 8/14/2025 | Voss Capital LP | 541,159 | $0.51M | 0.0% | +260.8% | 0.907% |  |
| 8/12/2025 | BIOS Capital Management LP | 3,683,429 | $3.46M | 4.8% | +270.1% | 6.174% |  |
| 5/16/2025 | AWM Investment Company Inc. | 524,245 | $0.52M | 0.1% | N/A | 1.153% |  |
| 5/15/2025 | Nantahala Capital Management LLC | 3,157,895 | $3.10M | 0.1% | N/A | 6.943% |  |
| 5/15/2025 | Royal Bank of Canada | 304,123 | $0.30M | 0.0% | N/A | 0.669% |  |
| 5/14/2025 | BIOS Capital Management LP | 995,249 | $0.98M | 1.2% | N/A | 2.188% |  |
| 5/14/2025 | Comerica Bank | 30,000 | $29K | 0.0% | N/A | 0.066% |  |
| 5/14/2025 | Mink Brook Asset Management LLC | 810,080 | $0.80M | 0.8% | N/A | 1.781% |  |
| 5/14/2025 | Voss Capital LP | 150,000 | $0.15M | 0.0% | N/A | 0.330% |  |
| 5/12/2025 | Virtu Financial LLC | 26,275 | $26K | 0.0% | N/A | 0.058% |  |
| 5/5/2025 | Kestra Private Wealth Services LLC | 48,341 | $47K | 0.0% | N/A | 0.106% |  |
| 5/2/2025 | Apollon Wealth Management LLC | 28,089 | $28K | 0.0% | N/A | 0.062% |  |
Data available starting January 2016
Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.
Read More on Opus Genetics
Volume
303,825 shs
Average Volume
908,164 shs
Market Capitalization
$320.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.45
Who are the company insiders with the largest holdings of Opus Genetics?
Who are the major institutional investors of Opus Genetics?
Opus Genetics' top institutional shareholders include:
- Nantahala Capital Management LLC — 6.93%
- Balyasny Asset Management L.P. — 3.94%
- Millennium Management LLC — 2.90%
- Mink Brook Asset Management LLC — 2.42%
- Opaleye Management Inc. — 1.62%
- Adage Capital Partners GP L.L.C. — 1.60%
Learn More about top institutional investors of Opus Genetics stock.
Which institutional investors are selling Opus Genetics stock?
Within the last quarter, IRD stock was sold by these institutional investors:
- Voss Capital LP
- Renaissance Technologies LLC
- XTX Topco Ltd
Which institutional investors are buying Opus Genetics stock?
During the last quarter, IRD stock was acquired by institutional investors including:
- Balyasny Asset Management L.P.
- Millennium Management LLC
- Nantahala Capital Management LLC
- Mink Brook Asset Management LLC
- Wells Fargo & Company MN
- Marshall Wace LLP
- Adage Capital Partners GP L.L.C.
- OMERS ADMINISTRATION Corp
Within the last year, these company insiders have bought Opus Genetics stock:
- Fighting Blindness Foundation (Director)
- Cam Gallagher (Director)
Learn More investors buying Opus Genetics stock.